Hepatic Artery Infusion therapy delivers treatment directly to metastatic tumors in the liver, while minimizing the potential for systemic side effects TAMPA, Fla., March 18, 2025 /PRNewswire/ -- ...
Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study The 3-year overall survival (OS) for advanced ...
Hepatic Artery Infusion therapy delivers treatment directly to metastatic tumors in the liver, while minimizing the potential for systemic side effects Hepatic Artery Infusion (HAI) therapy uses a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results